NOVORAPID Safety Questions, NOVORAPID Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about NOVORAPID. Our extensive database of NOVORAPID adverse events and NOVORAPID warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about NOVORAPID
NOVORAPID Safety Reports
Total NOVORAPID reports: 145.NOVORAPID FDA safety alerts: No.
Reported deaths: 14 Reported hospitalizations: 90.
Take NOVORAPID Side Effects Survey or Share Your NOVORAPID Story. Read More Here.
Showing 1-50 of 145 Next >
Physician from JAPAN reported NOVORAPID problem on May 25, 2007. Female patient, 55 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia, diabetic neuropathy, insomnia, constipation and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. NOVORAPID dosage: unknown. During the same period patient was treated with LANTUS, MEVALOTIN, KINEDAK, CYANOCOBALAMIN, LENDORMIN, ALOSENN, HUMALOG. Patient was hospitalized. Patient recovered.NOVORAPID problem was reported by a Physician from UNITED STATES on May 30, 2007. Male patient, weighting 173.6 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. NOVORAPID dosage: unknown. During the same period patient was treated with INSULIN DETEMIR FLEXPEN. Patient recovered.
Health Professional from JAPAN reported NOVORAPID problem on May 25, 2007. Male patient, 71 years of age, weighting 134.5 lb, was diagnosed with constipation, insomnia, hypertension, abdominal distension, polyuria and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: convulsions local, subdural haematoma. NOVORAPID dosage: unknown. During the same period patient was treated with MAGMITT, LENDORMIN, DIOVAN, DEXAMETHASONE PHOSPHATE, CALCICOL, ISOVORIN, FLIVAS. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on May 29, 2007. Female patient, 84 years of age, weighting 112.4 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, blood glucose fluctuation. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN R, HUMALOG. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported NOVORAPID problem on May 30, 2007. Male patient, weighting 142.6 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: fall, hypoglycaemia. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID FLEXPEN, ASPIRIN, GLICLAZIDE, GLUCOFORMIN, RAMIPRIL, OMEGA, CHONDNAL, VITAMIN C. Patient recovered.
NOVORAPID problem was reported by a Consumer or non-health professional from JAPAN on May 31, 2007. Male patient, 48 years of age, weighting 165.3 lb, was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, weight decreased. NOVORAPID dosage: unknown. During the same period patient was treated with HUMALOG, HUMACART N. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on June 01, 2007. Female patient, 41 years of age, weighting 138.9 lb, was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, headache, hyperglycaemia, urticaria. NOVORAPID dosage: unknown. During the same period patient was treated with HUMALOG. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from SERBIA AND MONTENEGRO on May 31, 2007. Female patient, 14 years of age, weighting 121.3 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, headache, hypoglycaemia, vomiting. NOVORAPID dosage: unknown. During the same period patient was treated with LEVEMIR. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported NOVORAPID problem on June 04, 2007. Male patient, weighting 173.6 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic unconsciousness. NOVORAPID dosage: unknown. During the same period patient was treated with INSULIN DETEMIR FLEXPEN. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on June 05, 2007. Male patient, 68 years of age, weighting 156.5 lb, was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, blood glucose increased, injection site pain. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVOLIN N, NOVOLIN R, LEVOFLOXACIN, MUCOSOLVAN, PREDNISOLONE, SELBEX. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on June 12, 2007. Male patient, 75 years of age, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. NOVORAPID dosage: unknown. During the same period patient was treated with DAONIL, METFORMIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
NOVORAPID problem was reported by a Pharmacist from SWEDEN on June 11, 2007. Male patient, 47 years of age, was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, fatigue, nausea, vomiting. NOVORAPID dosage: unknown. During the same period patient was treated with COZAAR COMPTE, SIMVASTATIN, TROMBYL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on June 15, 2007. Female patient, weighting 105.8 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperlipidaemia and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. NOVORAPID dosage: unknown. During the same period patient was treated with CONIEL, MEVALOTIN. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from SERBIA AND MONTENEGRO on June 14, 2007. Female patient, 14 years of age, weighting 121.3 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, headache, hypoglycaemia, vomiting. NOVORAPID dosage: unknown. During the same period patient was treated with LEVEMIR. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on June 22, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on June 29, 2006. Male patient, 53 years of age, weighting 158.7 lb, was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, intentional overdose, suicide attempt. NOVORAPID dosage: unknown. During the same period patient was treated with WARFARIN, GLICLAZIDE, DIGOXIN, SENNOSIDE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on July 03, 2006. Male patient, 67 years of age, was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: endocrine test abnormal. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVOLIN N, HUMALOG. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on Mar 01, 2006. Female patient, 14 years of age, weighting 94.80 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, blood glucose increased. NOVORAPID dosage: unknown. During the same period patient was treated with PENFILL N CHU. Patient recovered.
Health Professional from UNITED KINGDOM reported NOVORAPID problem on June 22, 2006. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dizziness, palpitations. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID PENFILL, INSULIN GLARGINE, GLUCOFORMIN, LISINOPRIL, SIMVASTATIN. Patient recovered.
NOVORAPID problem was reported by a Physician from UNITED KINGDOM on Apr 28, 2005. Female patient, 61 years of age, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dyspnoea. NOVORAPID dosage: unknown. During the same period patient was treated with LEVEMIR, CLOTRIMAZOLE, METFORMIN, ASPIRIN, RAMIPRIL, PRAVASTATIN, ACETAMINOPHEN W, FLUOXETINE. Patient recovered.
Physician from DENMARK reported NOVORAPID problem on June 02, 2006. Female patient, 58 years of age, weighting 149.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, angina pectoris, hypertension, oedema peripheral and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: angina pectoris. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID FLEXPEN, NOVORAPID FLEXPEN, CARDIL, ENALAPRIL MALEATE, FURIX. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on July 03, 2006. Male patient, 67 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus insulin-dependent, hypertension, nephrotic syndrome, diabetic retinopathy and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody increased, hypoglycaemia. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN N, HUMALOG, AMLODIN, TENORMIN, BLOPRESS, FRANDOL, PERSANTIN, ADONA. Patient was hospitalized. Patient recovered.
Physician from DENMARK reported NOVORAPID problem on May 24, 2006. Male patient, 57 years of age, weighting 224.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hyperlipidaemia, thrombosis prophylaxis, hypertension and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID FLEXPEN, ZARATOR, MAGNYL, TRIATEC, CARDIL, FURIX. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on June 29, 2006. Male patient, 53 years of age, weighting 158.7 lb, was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, loss of consciousness, overdose, suicide attempt. NOVORAPID dosage: unknown. During the same period patient was treated with WARFARIN, GLICLAZIDE, DIGOXIN, SENNOSIDE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported NOVORAPID problem on June 22, 2006. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: dizziness, palpitations. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID PENFILL, INSULIN GLARGINE, GLUCOFORMIN, LISINOPRIL, SIMVASTATIN. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on July 03, 2006. Male patient, 67 years of age, weighting 130.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, nephrotic syndrome, diabetic retinopathy and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody increased, blood glucose fluctuation. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN N, HUMALOG, AMLODIN, TENORMIN, BLOPRESS, FRANDOL, PERSANTIN, ADONA. Patient was hospitalized. Patient recovered.
Physician from DENMARK reported NOVORAPID problem on May 24, 2006. Male patient, 57 years of age, weighting 224.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hyperlipidaemia, thrombosis prophylaxis, hypertension and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: cholangitis. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID FLEXPEN, ZARATOR, MAGNYL, TRIATEC, CARDIL, FURIX. Patient recovered.
NOVORAPID problem was reported by a Physician from FRANCE on Aug 03, 2006. Female patient, 52 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: facial palsy, hypoglycaemia, loss of consciousness. NOVORAPID dosage: unknown. During the same period patient was treated with LANTUS, CRESTOR. Patient was hospitalized. Patient recovered.
Physician from DENMARK reported NOVORAPID problem on June 02, 2006. Female patient, 58 years of age, weighting 149.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, angina pectoris, hypertension, oedema peripheral and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: angina pectoris. NOVORAPID dosage: unknown. During the same period patient was treated with NOVORAPID FLEXPEN, NOVORAPID FLEXPEN, CARDIL, ENALAPRIL MALEATE, FURIX. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from FRANCE on Aug 03, 2006. Female patient, 52 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: facial palsy, headache, hypoglycaemia. NOVORAPID dosage: unknown. During the same period patient was treated with LANTUS, CRESTOR. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Sept 01, 2006. Male patient, 22 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, intentional overdose, suicide attempt. NOVORAPID dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from UNITED KINGDOM on May 30, 2006. Female patient, 44 years of age, weighting 163.1 lb, was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: joint swelling, nausea, swelling face, urticaria. NOVORAPID dosage: unknown. During the same period patient was treated with LISINOPRIL, INSULIN GLARGINE. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Sept 14, 2006. Female patient, 84 years of age, weighting 112.4 lb, was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, blood glucose fluctuation, hypoglycaemia. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN R, HUMALOG. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 21, 2006. Male patient was diagnosed with diabetes mellitus and was treated with NOVORAPID. NOVORAPID dosage: unknown. During the same period patient was treated with INSULATARD NPH. Patient died on 07/13/2006.
Physician from JAPAN reported NOVORAPID problem on Sept 14, 2006. Female patient, 84 years of age, weighting 112.4 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, blood glucose fluctuation. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN R, HUMALOG. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from UNITED KINGDOM on Aug 24, 2005. Male patient, 63 years of age, weighting 251.3 lb, was diagnosed with diabetes mellitus inadequate control and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: cellulitis. NOVORAPID dosage: unknown. During the same period patient was treated with GLICLAZIDE, METFORMIN, IBUPROFEN, ATORVASTATIN, DOXAZOSIN, RAMIPRIL, LIPANTIL, ATENOLOL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Sept 14, 2006. Female patient, 84 years of age, weighting 112.4 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, blood glucose fluctuation. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN R, HUMALOG. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on Sept 25, 2006. Male patient, 68 years of age, weighting 156.5 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, anti-insulin antibody positive, blood glucose increased, diabetes mellitus inadequate control, hypoglycaemia, injection site pain. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVOLIN N, NOVOLIN R, LEVOFLOXACIN, MUCOSOLVAN, PREDNISOLONE, SELBEX. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Oct 13, 2006. Female patient, 17 years of age, weighting 127.9 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, pneumonia. NOVORAPID dosage: unknown. During the same period patient was treated with PENFILL R CHU, PENFILL N CHU, LANTUS, HUMULIN, HUMACART R, HUMULIN N, HUMALOG. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on Oct 16, 2006. Female patient, 75 years of age, weighting 121.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, diabetic nephropathy and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis c, hypoglycaemia. NOVORAPID dosage: unknown. During the same period patient was treated with ADALAT, DIOVAN, WYTENS, FLUITRAN, KINEDAK, JUVELA NICOTINATE, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Oct 19, 2006. Female patient, 59 years of age, weighting 145.5 lb, was diagnosed with diabetes mellitus, hypertension and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, thrombocytopenia. NOVORAPID dosage: unknown. During the same period patient was treated with AMLODIN, MICARDIS, EUGLUCON. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 41 years of age, was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, hypoglycaemia, memory impairment, paralysis flaccid, somnolence. NOVORAPID dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Oct 13, 2006. Female patient, 17 years of age, weighting 127.9 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, pneumonia. NOVORAPID dosage: unknown. During the same period patient was treated with PENFILL R CHU, PENFILL N CHU, LANTUS, HUMULIN, HUMACART R, HUMULIN N, HUMALOG. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Health Professional from UNITED KINGDOM on Oct 25, 2006. Female patient was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anger, blood glucose decreased, suicide attempt. NOVORAPID dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Oct 19, 2006. Female patient, 59 years of age, weighting 145.5 lb, was diagnosed with diabetes mellitus, hypertension and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, thrombocytopenia. NOVORAPID dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, MICARDIS, EUGLUCON. Patient recovered.
NOVORAPID problem was reported by a Physician from JAPAN on Oct 31, 2006. Male patient, 64 years of age, weighting 123.5 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody increased, diabetes mellitus inadequate control. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVOLIN N, AMLODIPINE BESYLATE, LASIX, DIOVAN, LIVALO, ARTIST, BASEN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported NOVORAPID problem on Sept 25, 2006. Male patient, 68 years of age, weighting 156.5 lb, was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody, blood glucose increased, hypoglycaemia, injection site pain. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVOLIN N, NOVOLIN R, LEVOFLOXACIN, MUCOSOLVAN, PREDNISOLONE, SELBEX. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Health Professional from FRANCE on Nov 06, 2006. Female patient, 76 years of age, weighting 154.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: cholestasis, diabetes mellitus inadequate control, pneumonia, psoriasis, rash. NOVORAPID dosage: unknown. During the same period patient was treated with NOVOLOG, ATARAX, LEVOTHYROXINE, ACITRETIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported NOVORAPID problem on Oct 25, 2006. Female patient was diagnosed with diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, suicide attempt. NOVORAPID dosage: unknown. Patient was hospitalized. Patient recovered.
NOVORAPID problem was reported by a Physician from INDIA on Nov 15, 2006. Female patient was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVORAPID. After drug was administered, patient experienced the following problems/side effects: angina pectoris, blood glucose increased. NOVORAPID dosage: unknown. During the same period patient was treated with MIXTARD, ORAL ANTIDIABETICS, ACTRAPID. Patient was hospitalized. Patient recovered.
Showing 1-50 of 145 Next >